论文部分内容阅读
本文介绍了《抗疟药物使用规范》的制订和实施对我国疟疾患者个体生命健康和国家公共卫生安全的重要意义。本文在《抗疟药物使用规范》制订过程中,对如何以世界卫生组织相关的文件为指南,结合我国抗疟药物生产和供应的实际情况,以及我国在长期疟疾防治过程中积累的经验,并根据我国消除疟疾进程中的实际需求选择抗疟药物进行了说明。还对新制定的《抗疟药物使用规范》与世界卫生组织《疟疾治疗指南》第3版和原《抗疟药使用原则和用药方案》中抗疟药物使用剂量和疗程的差异进行了较为详细的描述,并对特殊情况下调整抗疟药物的剂量和疗程作了具体的解释,以便于临床医生和公卫医生在临床疟疾患者救治和消除疟疾进程中传染源控制时科学、合理、规范地使用抗疟药物。
This article describes the “anti-malarial drug use specification,” the formulation and implementation of malaria patients in China’s individual life and health and national public health and safety of great significance. This article in the “Anti-malarial Drug Use Specification” in the development process, how to WHO-related documents as a guide, combined with China’s anti-malarial drug production and supply of the actual situation, as well as our long-term malaria prevention and control process and accumulated experience The selection of anti-malarial drugs according to the actual needs in the process of eliminating malaria in our country was described. The differences between the new anti-malarial drug use regimen and the newly formulated “Anti-malarial Drug Use Specification” and the third edition of the World Health Organization’s “Guidelines for the Treatment of Malaria” and the original Anti-malarial Drug Use Principles and Regimens were described in detail , And explained the dose and course of adjustment of antimalarial drugs under special circumstances so that clinicians and public health officials can scientifically, reasonably and properly control the source of infection in the treatment and elimination of malaria in clinical malaria patients Use anti-malarial drugs.